e-Drug3D 862 |
TELITHROMYCIN DISCONTINUED
|
cas 191114-48-4 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
ATC code |
PK parameters F 57 PERCENT |
Target TARGET 50S RIBOSOMAL SUBUNIT PDB Ligand code = TEL (link to the list of PDB complexes) Download experimental 3D coordinates of TEL with added hydrogens |
DrugCentral Unknown |
Download SDF file | (1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone Formula: Calculated chemical properties: MW 812.00 NB_atoms 58 XLogP 4.93 PSA 151.98 NB_HD 1 NB_HA 15 fsp3 0.72 Lipinski(0=no;1=yes) 0 |
FDA NDA 021144 (pdf not found) INN (TELITHROMYCIN) KETEK (SANOFI AVENTIS US) APPROVAL= AP YEAR= 2004 NEWMOLECULARENTITY DISCONTINUED |
Other links: |